3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
23
Breast Neoplasms
16
Neoplasms by Site
2
Neoplasms
2
Neoplasm Metastasis
2
Breast Diseases
2
Stage II Prostate Adenocarcinoma
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Oligometastatic Prostate Carcinoma
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Endometrial Neoplasms
1
Dementia
1
Cognitive Dysfunction
1
Anatomic Stage III Breast Cancer AJCC v8
1
Advanced Breast Cancer
1
Interventions
Radiotherapy
2
Paclitaxel
2
Carboplatin
2
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Trastuzumab
1
Taxes
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiation
1
Mastectomy, Segmental
1
Mastectomy
1
Mass Spectrometry
1
Immunohistochemistry
1
Gene Expression Profiling
1
Fulvestrant
1
Fluorescent Antibody Technique
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Counseling
1
Chromatography, Liquid
1
Brachytherapy
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Gonadotropin-Releasing Hormone
×
1 year
×
Clear all
No trials found.